Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q3 2017 · 10-Q
Revenue$40.55M$40.55M+34.7% vs Q3 2016 Net Income-$24.46M-$24.46MN/M vs Q3 2016 EPS Diluted-$0.32-$0.32N/M vs Q3 2016 Operating Income-$22,739,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$21,814,000N/M Margins · derivedOperating margin-56.1%+17.3 pt vs Q3 2016
Net margin-60.3%+19.9 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 8, 2017 · 39 d after period end